Haematologic and immunologic function and patient-reported outcomes for the phase 3 RESONATE (TM) study of ibrutinib versus ofatumumab in relapsed/refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma
Year: 2015
Type: article
Source: British Journal of Haematology
Authors: Talha Munir, Jacqueline C. Barrientos, Susan O’Brien, Brown, Neil E. Kay, Nishitha Reddy, Steven Coutré, Constantine S. Tam, Stephen P. Mulligan, Ulrich Jaeger, Stephen Devereux, Chris Pocock, Tadeusz Robak, S. J. Schuster, Anna Schuh, Devinder Gill, Adrian Bloor, Claire Dearden, Carolina Moreno, Gavin Cull, Michael R. Hamblin, Jeffrey A. Jones, Tanja Kierschniak, Karl Eckert, Samuel Suzuki, Emily Hsu, Danelle F. James, John C. Byrd, Peter Hillmen
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3025548980